Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$232.24 - $267.23 $673,496 - $774,967
2,900 Added 82.86%
6,400 $1.56 Million
Q3 2023

Nov 14, 2023

BUY
$254.9 - $283.59 $586,270 - $652,257
2,300 Added 191.67%
3,500 $904,000
Q2 2023

Aug 14, 2023

SELL
$238.39 - $265.32 $95,356 - $106,128
-400 Reduced 25.0%
1,200 $316,000
Q1 2023

May 15, 2023

SELL
$229.71 - $259.35 $114,855 - $129,675
-500 Reduced 23.81%
1,600 $396,000
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $458,409 - $539,511
2,100 New
2,100 $0

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.